AKT1 and neoplasm: CBD has been reported to inhibit HER2-driven tumor cell proliferation by binding to the HER2 kinase domain, thereby reducing activation of the downstream PI3K/AKT and MAPK/ERK pathways, which are critical for cancer cell survival [14].